3-UREIDOPROPYLTRIETHOXYSILANE

We are 3-UREIDOPROPYLTRIETHOXYSILANE CAS:116912-64-2-or-23779-32-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Chemical Name:3-UREIDOPROPYLTRIETHOXYSILANE
CAS.NO:116912-64-2;23779-32-0
Synonyms:3-Ureidopropyltriethoxysilane; N-(Triethoxysilylpropyl)urea
Molecular Formula:C10H24N2O4Si
Molecular Weight:264.39400
 
Physical and Chemical Properties:
Density:0.91;
Boiling point:68^oC;
Flash point:14^oC;
Index of Refraction:1.39;
 
Specification:
Appearance:Colorless clear liquid with alcohol-like odor
Purity(GC):50% solution in Methanol
 
Packing:180 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It can be used with such polymers as epoxy, phenolic, furan and melamine resins, polyurethanes, PA, PBT, PE, EVA, PP, PVB, PVAC, acrylics and silicones.
It can be used as a size constituent of finish for glass fiber/glass fabric composites.
It can be used as an additive to phenolic, furan and melamine resins for foundry resins and abrasives.
It can be used as an additive for sealants and adhesives.
It can be used as an additive and/or primer for paints and varnishes to improve adhesion to the substrate.
 




Related News: The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).bisphenol AF Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.Pivaloyl chloride CAS:3282-30-2 Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.4-fluorofenol CAS:371-41-5 The API is not made by only one reaction from the raw materials but rather it becomes an API via several chemical compounds.The API is not made by only one reaction from the raw materials but rather it becomes an API via several chemical compounds.